SPDR S&P Biotech ETF Rating $168.23 -0.16 (-0.10%) Closing price 04:10 PM EasternExtended Trading$168.22 -0.01 (-0.01%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOwnershipRatingsShort Interest SPDR S&P Biotech ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XBI Aggregate RatingModerate Buy 2.72Holdings in XBI have an aggregate rating of Moderate Buy based on 442 analyst ratings issued in the past year covering 25 companies (33.2% of the portfolio).XBI Aggregate Price Target$168.23High Prediction$168.23Average Prediction$168.23Low Prediction$168.23Holdings in XBI have an aggregate price target of $168.23 and a range of $168.23 to $168.23 covering 25 companies (33.2% of the portfolio).XBI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy20 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 XBI Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.76%TWSTTwist Bioscience$153.10+2.0%1.5697 of 5 stars2.70$98.30 -35.8%10Positive NewsAnalyst ForecastInsider Trade1.61%ORKAOruka Therapeutics$96.54-2.9%2.923 of 5 stars2.82$134.30 39.1%11Positive News1.55%APGEApogee Therapeutics$134.96+0.0%1.6755 of 5 stars2.20$124.43 -7.8%20News CoveragePositive News1.46%PRAXPraxis Precision Medicines$367.85-2.5%3.3509 of 5 stars3.00$585.95 59.3%22Positive NewsAnalyst Forecast1.39%KYMRKymera Therapeutics$120.23-4.2%1.5466 of 5 stars2.88$127.17 5.8%24Positive NewsAnalyst Upgrade1.37%NTRANatera$338.70+0.1%2.7126 of 5 stars2.82$319.38 -5.7%221.37%DNTHDianthus Therapeutics$111.54+0.7%1.8867 of 5 stars2.93$124.27 11.4%14Positive News1.36%HALOHalozyme Therapeutics$106.92-0.1%3.8741 of 5 stars2.62$91.20 -14.7%13News CoveragePositive News1.36%PTGXProtagonist Therapeutics$149.50-1.3%1.6225 of 5 stars2.94$140.53 -6.0%18News CoveragePositive News1.33%RVMDRevolution Medicines$221.15+2.7%2.5445 of 5 stars2.95$193.28 -12.6%22Trending NewsAnalyst UpgradeInsider Trade1.32%MRNAModerna$142.77-4.6%1.4373 of 5 stars2.05$74.31 -47.9%19Trending NewsAnalyst ForecastGap Down1.31%INSMInsmed$121.39-2.4%3.3896 of 5 stars3.00$205.52 69.3%251.30%CGONCG Oncology$79.01+0.8%2.7672 of 5 stars2.71$83.18 5.3%141.29%RYTMRhythm Pharmaceuticals$112.53+0.6%2.9282 of 5 stars2.78$142.44 26.6%18Positive News1.29%SYRESpyre Therapeutics$93.612.4185 of 5 stars2.87$109.69 17.2%15Trending NewsAnalyst Forecast1.28%REGNRegeneron Pharmaceuticals$807.71-0.9%4.2824 of 5 stars2.60$800.36 -0.9%25Trending News1.27%ERASErasca$19.49+1.8%1.8366 of 5 stars2.64$22.09 13.3%11Positive News1.25%TVTXTravere Therapeutics$67.52+0.6%1.6758 of 5 stars2.69$61.67 -8.7%13Positive News1.23%PCVXVaxcyte$61.15+0.1%2.5114 of 5 stars2.50$86.00 40.6%8Positive News1.22%ROIVRoivant Sciences$37.58+2.3%1.9492 of 5 stars2.85$35.14 -6.5%13Positive NewsAnalyst Forecast1.20%RLAYRelay Therapeutics$19.42-0.2%2.9509 of 5 stars2.93$25.92 33.5%14News CoveragePositive NewsAnalyst Revision1.18%AMGNAmgen$436.99-0.8%4.2755 of 5 stars2.39$380.43 -12.9%31Trending News1.16%BMRNBioMarin Pharmaceutical$65.29-0.5%4.9078 of 5 stars2.75$88.79 36.0%24Positive NewsAnalyst Forecast1.15%ARWRArrowhead Pharmaceuticals$88.59-0.6%2.1594 of 5 stars2.62$97.33 9.9%13Positive News1.15%BBIOBridgeBio Pharma$78.68-0.9%3.2846 of 5 stars2.83$100.79 28.1%23 This page (NYSEARCA:XBI) was last updated on 8/27/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Biotech ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XBI Stock Alerts